FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35690211000001100: Erenumab (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109487301000001113 Erenumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    109487401000001117 Erenumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Erenumab Is a Monoclonal antibody false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Erenumab 140mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Erenumab 140mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Aimovig 140mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Erenumab 70mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Erenumab 70mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier
    Aimovig 70mg/1ml solution for injection pre-filled pens (Novartis Pharmaceuticals UK Ltd) 1 pre-filled disposable injection Has specific active ingredient False Erenumab Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start